These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31588877)

  • 21. Individualizing pharmacogenomic test results in the context of the microbiome.
    Haga SB
    Per Med; 2020 Nov; 17(6):459-468. PubMed ID: 33026284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
    Luzum JA; Pakyz RE; Elsey AR; Haidar CE; Peterson JF; Whirl-Carrillo M; Handelman SK; Palmer K; Pulley JM; Beller M; Schildcrout JS; Field JR; Weitzel KW; Cooper-DeHoff RM; Cavallari LH; O'Donnell PH; Altman RB; Pereira N; Ratain MJ; Roden DM; Embi PJ; Sadee W; Klein TE; Johnson JA; Relling MV; Wang L; Weinshilboum RM; Shuldiner AR; Freimuth RR;
    Clin Pharmacol Ther; 2017 Sep; 102(3):502-510. PubMed ID: 28090649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient insights on features of an effective pharmacogenomics patient portal.
    Truong TM; Lipschultz E; Schierer E; Danahey K; Ratain MJ; O'Donnell PH
    Pharmacogenet Genomics; 2020 Dec; 30(9):191-200. PubMed ID: 33017129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions.
    Reisberg S; Krebs K; Lepamets M; Kals M; Mägi R; Metsalu K; Lauschke VM; Vilo J; Milani L
    Genet Med; 2019 Jun; 21(6):1345-1354. PubMed ID: 30327539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
    Lunenburg CATC; Gasse C
    Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementing a personalized medicine program in a community health system.
    Dressler LG; Bell GC; Ruch KD; Retamal JD; Krug PB; Paulus RA
    Pharmacogenomics; 2018 Nov; 19(17):1345-1356. PubMed ID: 30345883
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Digital Health Applications for Pharmacogenetic Clinical Trials.
    Naik H; Palaniappan L; Ashley EA; Scott SA
    Genes (Basel); 2020 Oct; 11(11):. PubMed ID: 33114567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing Pharmacogenetic Testing Among Children's Hospitals.
    Brown JT; Ramsey LB; Van Driest SL; Aka I; Colace SI
    Clin Transl Sci; 2021 Mar; 14(2):692-701. PubMed ID: 33325650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical pharmacogenetics: how do we ensure a favorable future for patients?
    Wiltshire T; Dong OM
    Pharmacogenomics; 2018 Apr; 19(6):553-562. PubMed ID: 29620450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
    Marrero RJ; Cicali EJ; Arwood MJ; Eddy E; DeRemer D; Ramnaraign BH; Daily KC; Jones D; Cook KJ; Cavallari LH; Wiisanen Weitzel K; Langaee T; Newsom KJ; Starostik P; Clare-Salzer MJ; Johnson JA; George TJ; Cooper-DeHoff RM
    Clin Pharmacol Ther; 2020 Sep; 108(3):557-565. PubMed ID: 32460360
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Implementing comprehensive pharmacogenomics in a community hospital-associated primary care setting.
    Wick JA; Schmidlen T; Grande K; Moretz C; Ashcraft K; Green J; Moyer N; Blaxall BC
    J Am Pharm Assoc (2003); 2023; 63(1):188-192. PubMed ID: 36243653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lessons Learned When Introducing Pharmacogenomic Panel Testing into Clinical Practice.
    Rosenman MB; Decker B; Levy KD; Holmes AM; Pratt VM; Eadon MT
    Value Health; 2017 Jan; 20(1):54-59. PubMed ID: 28212969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Introducing personalized health for the family: the experience of a single hospital system.
    Huddleston KL; Klein E; Fuller A; Jo G; Lawrence G; Haga SB
    Pharmacogenomics; 2017 Nov; 18(17):1589-1594. PubMed ID: 29061078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
    Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
    Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.
    Ho TT; Gift M; Alexander E
    Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing pharmacogenetic testing in rural primary care practices: a pilot feasibility study.
    Dressler LG; Bell GC; Abernathy PM; Ruch K; Denslow S
    Pharmacogenomics; 2019 Apr; 20(6):433-446. PubMed ID: 30983513
    [No Abstract]   [Full Text] [Related]  

  • 37. Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy.
    Tuteja S; Salloum RG; Elchynski AL; Smith DM; Rowe E; Blake KV; Limdi NA; Aquilante CL; Bates J; Beitelshees AL; Cipriani A; Duong BQ; Empey PE; Formea CM; Hicks JK; Mroz P; Oslin D; Pasternak AL; Petry N; Ramsey LB; Schlichte A; Swain SM; Ward KM; Wiisanen K; Skaar TC; Van Driest SL; Cavallari LH; Bishop JR;
    Clin Transl Sci; 2022 Feb; 15(2):371-383. PubMed ID: 34562070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Personalized drug therapy based on genetics. Possibilities and examples from clinical practice].
    Stingl JC; Just KS; Kaumanns K; Schurig-Urbaniak M; Scholl C; von Mallek D; Brockmöller J
    Internist (Berl); 2016 Mar; 57(3):289-97. PubMed ID: 26830424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PARC report: a perspective on the state of clinical pharmacogenomics testing.
    Eichmeyer J; Rogers S; Formea CM; Giri J; Jones JS; Schnettler E; Schmidlen T; Glogowski E; Kurz RN
    Pharmacogenomics; 2020 Jul; 21(11):809-820. PubMed ID: 32635876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
    Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
    PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.